Life Technologies Corp
Invitrogen Corporation (former NASDAQ symbol: IVGN) was a large, multinational biotechnology company headquartered in Carlsbad, California. In November 2008, a merger between Applied Biosystems and Invitrogen was finalized. The new company is called Life Technologies.
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
Latest FEC Datacovers through committee's December 31, 2012 filing.
Summaryoverview of the committee's finances
- Total Raised:
- Total Spent:
- Cash on Hand:
Standardized Donation Informationcovers roughly through Q4 2012. may lag behind FEC section above, as donors and industries are identified by hand.
- Employee Color Block
- PAC Color Block
Republicans vs. Democratsin dollars
State vs. Federalin dollars
Top PAC Recipients
- Employee Color Block
- PAC Color Block
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Life Technologies Corp
Names of Lobbyists
Firm Hired Amount Life Technologies Corp $1,205,000 Gordon Thomas Honeywell Govt Affairs $140,000
Most Frequently Disclosed Lobbying Issues
- Law Enforcement & Crime,
- Fed Budget & Appropriations,
- Health Issues,
- Science & Technology,
- Medical Research & Clin Labs,
- Copyright, Patent & Trademark,
- Food Industry,
Most Frequently Disclosed Bills
Bill No. Title S.517 Katie Sepich Enhanced DNA Collection Act of 2011 H.R.988 Katie Sepich Enhanced DNA Collection Act of 2011 H.R.1249 America Invents Act H.R.1056 Patent Continuing Disclosure Act S.23 Patent Reform Act of 2011 S.1599 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 S.250 Katie Sepich Enhanced DNA Collection Act of 2012 S.3805 Katie Sepich Enhanced DNA Collection Act of 2010 H.R.2112 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012 H.R.3207 Modernizing Laboratory Test Standards for Patients Act of 2011
RegulationsMentioned in 6 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Life Technologies Corp" in public comments on proposed federal regulations.
Mentions in Document Text
View all mentions data for Life Technologies Corp
- Toggle 2 FDA Request to Disapprove Abbreviated New Drug Application 78-868 Filed by Apotex, Inc. for Generic Tizanidine Hydrochloride Capsules - CLOSED 2011
- Toggle 2 PTO Examination Guidelines for Implementing the First-Inventor-to-File Provisions of the Leahy-Smith America Invents Act 2012
- Toggle 1 FDA Take the Actions Described (1) Refuse to Approve any ANDA Referencing Lyrica That Contains an Isomeric Impurity Specification That Includes a “Not Less Than” Minimum Level or Otherwise Requires the Generic Product Covered by the ANDA to Contain an Isomeric Impurity.... 2012
- Toggle 1 FDA Patent Term Extension Application for SAPIEN®, U.S. Patent No. 5,411,552 2012
- Toggle 1 EPA Significant New Use Rules on Certain Chemical Substances 2011
- Toggle 1 FDA Assertion of Right of the United States to Use, or Authorize the Use of the Production Processes of Reference Monoclonal Antibody Products Approved under the Public Health Service Act 2012
Federal Spending1 contract
Federal grants, contracts and loans are reported by federal agencies using the FPDS and FAADS systems. The data is made available to the public at USASpending.gov. Please note that the completeness and quality of the data varies greatly by agency.
Only grants, contracts and loans with amounts over $1 million are shown.
Because company names are not reported in a standardized manner, we cannot reliably determine the company receiving the contract or award. The results shown here are based on a search for the company name. Individual records may be missed or erroneously included because of name variations. For more information, please see our federal spending methodology page.
Note: Company names in federal spending data are not standardized. The table below is included only as a sample of what is available in the data and has not been reviewed for accuracy or completeness. To investigate the data further, use the links at the bottom of the table.
|Life Technologies Corporation||2012||Office Of Asst Secretary For Health Except National Centers||DNA REACTIONS||$1,883,252|